Recently, Chung et al. [118] fabricated PEI-coated iron oxide nanoparticles to deliver O6-methylguanine-DNA methyltransferase (MGMT)-targeting siRNA to glioma cells for inhibiting MGMT activity and subsequent reduction of resistance to chemotherapy agents such as Temozolomide (TMZ). This evidence concerns the gene MGMT and central nervous system cancer.